SAN FRANCISCO and BOSTON, Jan. 09, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (MapLight) (Nasdaq: MPLT) today announced an update to the expected timing of topline results for its ongoing ...
Newleos Therapeutics, Inc., a clinical-stage biotechnology company developing innovative treatments for neuropsychiatric ...
Morning Overview on MSN
A dust-sized device could supercharge quantum computers
A device smaller than a grain of dust is emerging as a surprisingly powerful candidate to reshape how quantum computers are ...
Impressively, the unit registered the lowest frequency loss of any chip to date. Specifically, the engineers noted that the new chip was 15x more stable and 100x more efficient in terms of microwave ...
Abstract: This article presents the development, implementation, and validation of a loss-optimized and circuit parameter-sensitive triple-phase-shift (TPS) modulation scheme for a dual-active-bridge ...
Even though the function of single phase and three phase relays are quite similar, their applications can vary significantly. This is primarily due to the characteristics of three phase power circuits ...
Demonstrated strong safety and favorable pharmacokinetics in Phase 1 study A First-in-class oral small molecule modulating immune cell metabolism via glycogen phosphorylase inhibition Once-daily oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback